Anika Therapeutics ANIK Balance Sheet (2010-2026)

NASDAQ ANIK
$19.94 -0.74 (-3.55%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Anika Therapeutics Quarterly Balance Sheet

Periods 65 quarters
Latest Jun 2026

Anika Therapeutics reported total assets of $183.47M and total liabilities of $46.19M for the quarter ended Jun 2026, down 2.2% year over year. This balance sheet covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
90.98M94.39M90.33M91.39M87.78M86.33M79.74M65.07M70.65M68.74M68.63M62.82M62.37M55.63M53.37M53.17M57.99M57.48M41.02M38.41M
Short-term InvestmentsInvestments (Current)
29.84M29.31M32.17M34.17M34.63M30.63M36.74M34.68M26.36M32.08M33.77M28.36M23.59M21.99M23.95M22.19M23.69M25.77M
Cash & Current Investments
90.98M124.23M119.64M123.56M121.94M120.95M110.37M101.81M105.33M95.10M100.71M96.59M90.72M79.22M75.36M77.12M80.18M81.17M66.79M38.41M
Receivables - NetNet Receivables
32.35M29.84M34.63M30.63M36.74M34.68M26.36M32.08M33.77M28.36M23.59M21.99M23.95M22.19M23.69M25.77M29.06M
Receivables
32.35M29.84M34.63M30.63M36.74M34.68M26.36M32.08M33.77M28.36M23.59M21.99M23.95M22.19M23.69M25.77M29.06M
Raw Materials
Work In Process
Finished Goods
Inventory
35.02M36.01M35.23M35.34M37.24M39.77M41.32M42.60M43.72M24.43M49.41M51.46M39.63M23.81M21.34M16.92M16.28M18.79M22.84M28.57M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
7.43M8.29M10.46M8.96M8.58M8.83M8.65M7.79M7.72M7.48M8.85M6.94M5.75M5.49M5.82M5.27M5.13M3.40M3.94M3.15M
Current Assets
165.78M168.53M165.32M167.86M167.76M169.55M160.33M152.20M156.78M163.31M158.96M155.00M136.11M113.65M102.51M99.32M101.59M103.36M93.56M99.19M
Non-Current Assets
Construction in Progress
Property, Plant & Equipment (Net)PP&E (Net)
49.11M47.60M47.95M48.09M47.39M48.28M48.80M47.99M45.94M37.45M46.06M47.69M44.57M38.99M40.46M40.68M40.68M40.32M39.72M40.10M
Goodwill
7.95M7.78M7.62M7.17M6.72M7.34M7.46M7.47M7.25M7.57M7.40M7.35M7.66M7.12M7.42M8.06M8.05M8.05M7.89M7.83M
Intangibles
85.02M82.38M80.44M78.49M76.55M74.60M72.65M70.71M68.76M2.58M4.30M3.97M3.08M2.49M1.70M1.66M1.65M1.70M1.70M1.70M
Goodwill & Intangibles
92.97M90.16M88.06M85.66M83.27M81.94M80.11M78.17M76.02M10.15M11.70M11.32M10.74M9.62M9.12M9.72M9.70M9.75M9.59M9.53M
Long-Term Deferred Tax
1.45M1.52M1.50M1.42M1.49M1.27M1.36M1.47M1.18M1.19M1.25M1.25M1.27M1.15M1.02M
Other Non-Current Assets
23.67M20.29M20.39M20.91M18.34M17.22M18.13M19.39M18.95M24.96M17.57M19.52M11.31M5.66M5.72M5.55M5.51M4.03M4.30M3.02M
Non-Current Assets
187.15M179.01M176.92M186.27M179.99M179.58M178.74M176.68M171.38M107.32M104.78M107.66M95.30M89.09M88.10M88.36M87.85M86.91M85.83M84.28M
Assets
352.93M347.54M342.24M354.12M347.75M349.13M339.07M328.88M328.16M270.63M263.74M262.65M231.41M202.74M190.60M187.68M189.44M190.27M179.39M183.47M
Liabilities
Current Liabilities
Accounts Payables
7.94M7.63M7.44M8.16M8.35M9.07M8.95M7.94M8.25M6.19M10.02M9.99M6.80M5.62M5.28M4.77M4.73M6.04M6.34M6.24M
Payables
7.94M7.63M7.44M8.16M8.35M9.07M8.95M7.94M8.25M6.19M10.02M9.99M6.80M5.62M5.28M4.77M4.73M6.04M6.34M6.24M
Accumulated Expenses
17.34M17.85M15.23M16.95M18.00M18.84M19.75M15.51M19.81M14.07M18.44M16.13M18.69M13.57M12.62M11.31M14.36M15.87M14.63M15.91M
Other Accumulated Expenses
17.34M1.06M1.15M1.03M0.50M0.51M0.57M0.54M0.51M0.34M0.48M0.52M0.38M0.77M0.78M0.64M0.75M0.47M0.48M0.33M
Short term Debt
Current Leases
0.19M0.12M0.13M
Current Taxes
0.81M0.89M0.93M0.82M1.24M1.49M0.08M0.08M0.06M0.07M
Current Deferred Revenue
0.23M0.12M
Total Current Liabilities
28.77M29.80M26.99M29.43M26.35M27.91M28.69M23.46M28.06M31.06M28.46M26.12M25.49M23.31M17.90M16.08M19.09M21.91M20.97M22.15M
Non-Current Liabilities
Non-Current Debt
Non-Current Deffered Revenue
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
0.99M0.66M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
12.97M10.16M9.96M8.22M6.80M6.44M4.11M3.23M1.96M
Operating Leases
19.64M19.24M18.82M29.73M29.18M28.82M28.28M27.77M27.25M25.91M26.34M25.79M25.24M24.01M23.56M23.17M22.78M24.20M23.79M23.32M
Other Non-Current Liabilities
1.49M1.26M0.68M0.59M0.47M0.40M0.40M0.40M0.40M0.40M0.40M0.41M0.81M0.77M0.74M0.76M0.76M0.70M0.73M0.73M
Total Non-Current Liabilities
61.38M59.19M55.77M67.38M62.34M63.17M61.09M54.47M57.27M57.96M54.80M51.91M50.73M47.98M41.46M39.25M41.87M46.10M44.76M45.46M
Total Liabilities
62.87M60.45M56.45M67.97M62.81M63.56M61.49M54.87M57.67M58.37M55.21M52.32M51.54M48.75M42.21M40.01M42.63M46.80M45.49M46.19M
Shareholder's Equity
Total Debt
Common Equity
290.06M287.08M285.79M286.15M284.94M285.56M277.59M274.01M270.49M212.26M208.54M210.34M179.86M153.99M148.40M147.67M146.81M143.47M133.90M137.28M
Liabilities and Shareholders Equity
352.93M347.54M342.24M354.12M347.75M349.13M339.07M328.88M328.16M270.63M263.74M262.65M231.41M202.74M190.60M187.68M189.44M190.27M179.39M183.47M
Retained Earnings
231.37M225.58M222.65M219.80M215.63M210.72M200.37M197.63M191.05M128.05M123.54M123.45M93.53M71.67M66.79M62.82M60.49M60.79M55.73M59.04M

Anika Therapeutics Balance Sheet API

Pull Anika Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ANIK&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY